Tag: regulatory_policy
-
FDA Seeks Public Comment on Removing 510(k) Clearance for Federal Drug Testing
The FDA proposes removing the 510(k) clearance requirement for federal drug testing programs, including DOT's. This change impacts laboratories and testing providers. The DOT urges stakeholders to review the proposal and submit comments by June 30, 2026.
Politics and GovernmentHealthBusinessFederal GovernmentGeneral PoliticsMedical ScienceEmployment and LaborLegal FDADepartment of TransportationDrug Testing510(k) ClearanceFederal RegisterPublic CommentRegulatory PolicyDOT - Office of Drug & Alcohol Policy & Compliance
-
NRC Proposes Sweeping Updates to Radioactive Material Regulations
The Nuclear Regulatory Commission has proposed major updates to its rules governing radioactive materials in medicine, industry, and research. The changes aim to streamline licensing, reduce paperwork, and modernize requirements while maintaining strict safety standards.
Politics and GovernmentHealthScience & TechnologyBusinessFederal GovernmentMedical ScienceEnergyLegalEconomyState Governments Nuclear Regulatory CommissionRadioactive MaterialsMedical ImagingIndustrial RadiographyRegulatory PolicyGovernment AgencyHealthcareU.S. Nuclear Regulatory Commission (NRC)
-
Treasury Secretary Scott Bessent Meets with Insurance Commissioners on Private Credit
Treasury Secretary Scott Bessent convened with state insurance commissioners and the NAIC to discuss the U.S. life insurance sector, focusing on private credit markets, offshore reserves, and the need for balanced regulation that manages risk while encouraging innovation.
Business and FinanceInsuranceScott BessentU.S. Department of the TreasuryNAICPrivate CreditRegulatory PolicyUS Treasury